The pharmacokinetics and metabolism of Kö592 in man, dog and rat.
作者信息
Arndts D, Pollmann W
出版信息
Naunyn Schmiedebergs Arch Pharmacol. 1973;277(4):349-62. doi: 10.1007/BF00500995.
PMID:4145200
Abstract
摘要
相似文献
1
The pharmacokinetics and metabolism of Kö592 in man, dog and rat.Kö592在人、狗和大鼠体内的药代动力学及代谢情况。
Naunyn Schmiedebergs Arch Pharmacol. 1973;277(4):349-62. doi: 10.1007/BF00500995.
2
Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.β肾上腺素能拮抗剂心得宁在人体的药代动力学研究。
Clin Pharmacol Ther. 1973 Jan-Feb;14(1):26-9. doi: 10.1002/cpt197314126.
3
[Studies on cardiovascular drugs. 8. Metabolism of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].[心血管药物研究。8. 盐酸1-叔丁氨基-3-(邻-(四氢糠氧基)苯氧基)-2-丙醇(Y-6124)的代谢]
Yakugaku Zasshi. 1972 Mar;92(3):299-304. doi: 10.1248/yakushi1947.92.3_299.
4
Metabolism of a beta blocking drug, oxprenolol.一种β受体阻滞剂药物氧烯洛尔的代谢。
J Pharmacol Exp Ther. 1971 Nov;179(2):354-8.
5
Bunolol metabolism by dogs: isolation and identification of two acidic metabolites.犬体内布诺洛尔的代谢：两种酸性代谢产物的分离与鉴定
J Pharm Sci. 1971 Oct;60(10):1516-9. doi: 10.1002/jps.2600601016.
6
The metabolites of procaterol HCl in urine and faeces of dog and man.盐酸丙卡特罗在犬和人尿液及粪便中的代谢产物。
Xenobiotica. 1978 Nov;8(11):705-10. doi: 10.3109/00498257809069582.
7
Absorption, tissue distribution, and excretion of bunolol- 14 C by dogs.犬体内布诺洛尔-14C的吸收、组织分布及排泄
J Pharm Sci. 1971 Oct;60(10):1512-5. doi: 10.1002/jps.2600601015.
8
The disposition of butriptyline in rats, dogs and man.布替林在大鼠、狗和人体中的处置情况。
Arzneimittelforschung. 1974 Jan;24(1):93-6.
9
The metabolism of probenecid in man.丙磺舒在人体中的代谢。
Ann N Y Acad Sci. 1971 Jul 6;179:399-402. doi: 10.1111/j.1749-6632.1971.tb46916.x.
10
Pharmacokinetics and metabolism of a new beta-adrenergic blocking agent, the 1, ter-butyl-amino-3-(1,2,3,4-tetrahydro-1,4-ethano-8-hydroxy-5-naphthoxy)-2-propanol (K 5407).一种新型β-肾上腺素能阻滞剂1-叔丁基氨基-3-（1,2,3,4-四氢-1,4-亚乙基-8-羟基-5-萘氧基）-2-丙醇（K 5407）的药代动力学和代谢
Eur J Drug Metab Pharmacokinet. 1980;5(1):9-20. doi: 10.1007/BF03189437.
引用本文的文献
1
Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs.14C标记的阿利尼定在人和犬体内的药代动力学及代谢情况
Eur J Drug Metab Pharmacokinet. 1981;6(3):225-36. doi: 10.1007/BF03189492.
本文引用的文献
1
[Blood withdrawal from the retro-orbital venous plexus].[从眶后静脉丛取血]
Klin Wochenschr. 1955 Aug 15;33(31-32):770-1. doi: 10.1007/BF01473520.
2
[Pharmacology of some phenoxypropanolamine derivatives with beta-adrenolytic effects].[某些具有β-肾上腺素能阻断作用的苯氧丙醇胺衍生物的药理学]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;263(1):203-4.
3
[Hemodynamics after beta-receptor blockade].[β受体阻断后的血流动力学]
Z Kreislaufforsch. 1969 Jun;58(6):586-92.
4
[On the effects of an beta-adrenolytic substance on the functional parameters of blood circulation].[关于一种β-肾上腺素能阻断物质对血液循环功能参数的影响]
Z Kreislaufforsch. 1969 Apr;58(4):440-7.
5
Antiarrhythmic activity of the beta-adrenergic blocking agent 1-isopropylamino-3-(3-tolyloxy)-2-propanol (ICI 45763).β-肾上腺素能阻滞剂1-异丙氨基-3-（3-甲苯氧基）-2-丙醇（ICI 45763）的抗心律失常活性。
Am Heart J. 1969 Jan;77(1):63-71. doi: 10.1016/0002-8703(69)90130-6.
6
[On the relationship between the beta-adrenolytic action and the effect on the heart rate and cardiac output of beta-receptor blocking agents].[关于β-肾上腺素能阻断作用与β受体阻滞剂对心率及心输出量的影响之间的关系]
Klin Wochenschr. 1967 Nov 1;45(21):1087-92. doi: 10.1007/BF01754039.
7
[Controlled study of the beta-receptor blockader Kö 592 in patients with angina pectoris].β受体阻滞剂Kö 592治疗心绞痛患者的对照研究
Dtsch Med J. 1971 Jul;22(14):455-62.
8
9
The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle.肾上腺素能β受体阻断药对人心肌的负性肌力作用。
Cardiovasc Res. 1969 Jan;3(1):30-6. doi: 10.1093/cvr/3.1.30.
10
[Load insufficiency of the heart due to beta receptor blocking agents].β受体阻滞剂所致的心脏负荷不足
Med Klin. 1969 Sep 12;64(37):1663-8.
Zotero 插件